Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
Phenotypic Assays and Sequencing Are Less Sensitive Than Point Mutation Assays for Detection of Resistance in Mixed HIV-1 Genotypic Populations
Kristel Van Laethem, Kristien Van Vaerenbergh, Jean‐Claude Schmit, S Sprecher, P. Hermans, Véronique De Vroey, Rob Schuurman, Thomas Harrer, Myriam Witvrouw, Eric Van Wijngaerden, Lieven Stuyver, Marc Van Ranst, Jan Desmyter, De Clercq Erik, Anne‐Mieke Vandamme (1999). Phenotypic Assays and Sequencing Are Less Sensitive Than Point Mutation Assays for Detection of Resistance in Mixed HIV-1 Genotypic Populations. , 22(2), DOI: https://doi.org/10.1097/00126334-199910010-00001.
Article39 days agoInitiation of HAART in Drug-Naive HIV Type 1 Patients Prevents Viral Breakthrough for a Median Period of 35.5 Months in 60% of the Patients
Kristien Van Vaerenbergh, Thomas Harrer, Jean‐Claude Schmit, An Carbonez, Elodie Fontaine, Michael Kurowski, Mathias Grünke, Peter Löw, Astrid Rascu, Bárbara Schmidt, Matthias Schmitt, Inge Thoelen, H Walter, Kristel Van Laethem, Marc Van Ranst, Jan Desmyter, De Clercq Erik, Anne‐Mieke Vandamme (2002). Initiation of HAART in Drug-Naive HIV Type 1 Patients Prevents Viral Breakthrough for a Median Period of 35.5 Months in 60% of the Patients. , 18(6), DOI: https://doi.org/10.1089/088922202753614182.
Article39 days agoPatient HIV-1 strains carrying the multiple nucleoside resistance mutations are cross-resistant to abacavir
Kristel Van Laethem, Myriam Witvrouw, Jan Balzarini, Jean‐Claude Schmit, S Sprecher, Philippe Hermans, Manuel Leal, Thomas Harrer, Lı́dia Ruiz, Bonaventura Clotet, Marc Van Ranst, Jan Desmyter, De Clercq Erik, Anne‐Mieke Vandamme (2000). Patient HIV-1 strains carrying the multiple nucleoside resistance mutations are cross-resistant to abacavir. , 14(4), DOI: https://doi.org/10.1097/00002030-200003100-00027.
Letter39 days agoInitiation of HAART in drug naive HIV-1 patients prevents viral breakthrough for up to 43 months in 60% of the patients
Anne‐Mieke Vandamme, Kristien Van Vaerenbergh, JC Schmit, B. Schmidt, H Walter, Elodie Fontaine, Marie‐Paule Schmitt, Kristel Van Laethem, Astrid Rascu, De Vroey, Mathias Grünke, Phillip A. Low, Marc Van Ranst, Jan Desmyter, De Clercq Erik, Thomas Harrer (2000). Initiation of HAART in drug naive HIV-1 patients prevents viral breakthrough for up to 43 months in 60% of the patients. , 14
Article39 days agoPhenotypic assays and sequencing are less sensitive for the detection of resistance in mixed genotypes compared to point mutation assays
Kristel Van Laethem, Kristien Van Vaerenbergh, JC Schmit, S Sprecher, P Hermans, De Vroey, Rob Schuurman, Thomas Harrer, Myriam Witvrouw, Eric Van Wijngaerden, De Clercq Erik, Jan Desmyter, Anne‐Mieke Vandamme (1998). Phenotypic assays and sequencing are less sensitive for the detection of resistance in mixed genotypes compared to point mutation assays.
Article39 days ago